Re­call re­port: No­vo Nordisk re­calls sam­ples of mul­ti­ple in­sulin prod­ucts af­ter stor­age screw-up

Five dif­fer­ent in­sulin drugs have been re­called by No­vo Nordisk af­ter the com­pa­ny says the sam­ples were stored at the wrong tem­per­a­ture.

The re­call af­fects 1,468 prod­uct sam­ples of Lev­emir, Tre­si­ba, Fi­asp, No­volog and Xul­to­phy. The re­call on­ly im­pacts sam­ples, and not prod­uct that’s been dis­trib­uted to phar­ma­cies or mail-or­der ser­vices, the FDA said.

If sam­ples are ex­posed to tem­per­a­tures be­low 32 de­grees Fahren­heit, it could dam­age the ef­fi­ca­cy of the drug and the car­tridge and pen-in­jec­tors. It that prod­uct is used, pa­tients run the risk of not re­ceiv­ing the prop­er dosage, which could lead to hy­per­glycemia or hy­po­glycemia.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.